SFS
TRIL

Sowell Financial Services’s Trillium Therapeutics Inc. TRIL Stock Holding History

Sowell Financial Services’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,330
Closed -$12K – 3134
2021
Q1 		$12K Hold
1,330
– – ﹤0.01% 2259
2020
Q4 		$20K Buy
1,330
+580
+77% +$8.36K ﹤0.01% 1760
2020
Q3 		$11K Buy
+750
New +$7.48K ﹤0.01% 1795

Other funds holding TRIL

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Sowell Financial Services's TRIL Position: Q2 2021 in Review

Sowell Financial Services sold out of Trillium Therapeutics Inc. (TRIL) in Q2 2021, closing a stake of 1,330 shares — an estimated $12K sold.

Sowell Financial Services first reported a position in TRIL in Q3 2020 and held it in 3 quarters. The position peaked at $20K in Q4 2020. 137 funds tracked by Wall St. Rank hold TRIL as of Q2 2021.

  • Sowell Financial Services reported no remaining Trillium Therapeutics Inc. position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 1,330 Trillium Therapeutics Inc. shares in Q2 2021, an estimated $12K.
  • Sowell Financial Services first reported a position in Trillium Therapeutics Inc. in Q3 2020 and held it in 3 quarters.
  • Sowell Financial Services's Trillium Therapeutics Inc. position peaked at $20K in Q4 2020.
  • 137 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.